Linda L. Garland
University of Arizona(US)Virginia Commonwealth University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, Occupational and environmental lung diseases, Pleural and Pulmonary Diseases, Cancer Treatment and Pharmacology, Lung Cancer Research Studies
Most-Cited Works
- → Phase II Trial of Erlotinib Plus Concurrent Whole-Brain Radiation Therapy for Patients With Brain Metastases From Non–Small-Cell Lung Cancer(2013)393 cited
- → Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study(2010)320 cited
- → Phase II Study of the Anti–Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non–Small-Cell Lung Cancer(2009)262 cited
- → Phase II Study of Erlotinib in Patients With Malignant Pleural Mesothelioma: A Southwest Oncology Group Study(2007)220 cited
- Selenium supplementation and lung cancer incidence: an update of the nutritional prevention of cancer trial.(2002)
- → Interactive Sensor-Based Balance Training in Older Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Randomized Controlled Trial(2015)139 cited